Eric H. Rubin
MD
Senior Vice President, Global Clinical Development (Oncology)
👥Biography 个人简介
Eric Rubin leads oncology clinical development at Merck and has directed registrational programs for multiple approved cancer therapies including pembrolizumab. He has contributed to endpoint selection and trial design for immune checkpoint inhibitors. His work has shaped the regulatory approval landscape for modern oncology drugs.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Eric H. Rubin 的研究动态
Follow Eric H. Rubin's research updates
留下邮箱，当我们发布与 Eric H. Rubin（Merck Research Laboratories）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment